23.06.2020 21:15:26
|
J&J Damages Cut By More Than Half In Talcum Powder Cancer Suit
(RTTNews) - A Missouri appeals court on Tuesday reduced a damages award against Johnson & Johnson to about $2.12 billion from $4.69 billion in a case brought by 22 women and their families who alleged that decades of daily use of Johnson & Johnson's asbestos-laden talcum powder products caused their ovarian cancer, according to reports.
The Missouri Court of Appeals reportedly awarded $500 million in actual damages and $1.62 billion in punitive damages, compared to the original verdict from a Missouri circuit court of $550 million of actual damages and $4.14 billion of punitive damages.
The company had appealed a July 2018 St. Louis jury verdict. The company has faced thousands of lawsuits over the safety of talc in its Baby Powder.
In May 2020, Johnson & Johnson said it would stop selling its talc-based Johnson's Baby Powder in the United States and Canada, as demand fell amid mounting consumers lawsuits that claimed the talc products caused cancer.
However, the company then stated that cornstarch-based baby powder would remain available in North America. Both talc-based and cornstarch-based baby powder would continue be available in other markets around the world.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Johnson & Johnsonmehr Nachrichten
18:02 |
Dow Jones-Handel aktuell: Dow Jones verbucht Gewinne (finanzen.at) | |
16:04 |
Dow Jones 30 Industrial-Wert Johnson Johnson-Aktie: So viel Gewinn hätte ein Johnson Johnson-Investment von vor 10 Jahren abgeworfen (finanzen.at) | |
16:04 |
Schwacher Handel in New York: Dow Jones beginnt die Mittwochssitzung im Minus (finanzen.at) | |
07.01.25 |
Börse New York: Dow Jones legt zum Handelsende den Rückwärtsgang ein (finanzen.at) | |
07.01.25 |
Dow Jones-Handel aktuell: Dow Jones verbucht Verluste (finanzen.at) | |
07.01.25 |
Dow Jones-Handel aktuell: Dow Jones mit Abgaben (finanzen.at) | |
07.01.25 |
Erste Schätzungen: Johnson Johnson präsentiert Quartalsergebnisse (finanzen.net) | |
01.01.25 |
Dow Jones 30 Industrial-Papier Johnson Johnson-Aktie: Hätte sich eine Kapitalanlage in Johnson Johnson von vor 5 Jahren rentiert? (finanzen.at) |
Analysen zu Johnson & Johnsonmehr Analysen
Aktien in diesem Artikel
Johnson & Johnson | 137,50 | -2,77% |